Posttraumatic midazolam administration does not influence brain damage after experimental traumatic brain injury

BACKGROUND: The benzodiazepine midazolam is a γ-aminobutyric acid (GABA)-A receptor agonist frequently used for sedation or stress control in patients suffering from traumatic brain injury (TBI). However, experimental studies on benzodiazepines have reported divergent results, raising concerns about...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebastiani, Anne, Bender, Simone, Schäfer, Michael K. E., Thal, Serge C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896377/
https://www.ncbi.nlm.nih.gov/pubmed/35246037
http://dx.doi.org/10.1186/s12871-022-01592-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896377/
https://www.ncbi.nlm.nih.gov/pubmed/35246037
http://dx.doi.org/10.1186/s12871-022-01592-x

Ejemplares similares